Research and analysis

Healthcare associated infections (HAI): point prevalence survey, England

A point prevalence survey on levels of healthcare-associated infections (HAI) and levels of antimicrobial use in hospitals in England in 2016.

• From: Public Health England
• Published: 1 May 2012
• Last updated: 1 August 2016 — See all updates

Documents

Point prevalence survey of healthcare-associated infections and antimicrobial use in European acute-care hospitals: Codebook

Ref: PHE publications gateway number 2016185

PDF, 987 KB, 63 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Point prevalence survey of healthcare-associated infections, antimicrobial use and antimicrobial stewardship: Protocol

Ref: PHE publications gateway number 2016185

PDF, 718 KB, 29 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Point Prevalence Survey 2016: data collection forms and flow charts

Ref: PHE gateway number 2016185

PDF, 509 KB, 19 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

Over 4 million people in Europe get a healthcare-associated infection (HAI) every year, and around 37,000 die as a direct result of the infection. Antimicrobial use (AMU) is a key driver of antimicrobial resistance (AMR); understanding the indications, dose used, and adherence to guidelines is important to reduce antibiotic consumption.

Surveillance of HAI and AMU is an essential part of infection prevention and antimicrobial stewardship. It drives action by planning and implementing more effective, evidence based policies, surveillance and strategies.

The objectives of the point prevalence survey of HAIs and AMU in acute-care hospitals are to:

• estimate the total burden (prevalence) of HAIs and AMU in acute-care hospitals;
• describe patients, invasive procedures, infections (sites, microorganisms including markers of antimicrobial resistance) and antimicrobials prescribed (compounds, indications)
• describe key structures and processes for the prevention of HAIs and antimicrobial resistance at the hospital and ward level in EU hospitals
• disseminate results to those who need to know at local, regional and national levels

Published 1 May 2012
Last updated 1 August 2016 + show all updates

1. 1 August 2016

   Updated page with 2016 documents and details.

2. 1 May 2012

   First published.